In patients with metabolic-associated steatotic liver disease or metabolic-associated steatohepatitis, resmetirom and ...

The British Horseracing Authority (BHA) has today published the following updates regarding medication control. This includes ...

The cannabinoid agonist market is gaining momentum due to expanding medical cannabis legalization and growing clinical validation for its use in chro ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

New data and analyses presented at the American Diabetes Association’s annual meeting highlight the priorities for the next ...

Colorful dyes, chemical preservatives, and other once-common additives are now banned in many parts of the world as we better ...

DelveInsight's Epilepsy pipeline report depicts a robust space with 75+ active players working to develop 90+ pipeline ...

As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect millions of people ...

Autoimmune diseases, like multiple sclerosis result when the body's immune system starts to attack its own cells. Regulatory T cells, a subtype of T cells play a critical role in suppressing these ...

Patients with glaucoma using fixed combination therapy may experience faster presbyopia progression than those using monotherapy.